Daniela Francisci

4.8k total citations
146 papers, 2.7k citations indexed

About

Daniela Francisci is a scholar working on Infectious Diseases, Epidemiology and Emergency Medicine. According to data from OpenAlex, Daniela Francisci has authored 146 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 70 papers in Infectious Diseases, 48 papers in Epidemiology and 29 papers in Emergency Medicine. Recurrent topics in Daniela Francisci's work include HIV-related health complications and treatments (26 papers), HIV Research and Treatment (25 papers) and HIV/AIDS drug development and treatment (25 papers). Daniela Francisci is often cited by papers focused on HIV-related health complications and treatments (26 papers), HIV Research and Treatment (25 papers) and HIV/AIDS drug development and treatment (25 papers). Daniela Francisci collaborates with scholars based in Italy, United States and Iran. Daniela Francisci's co-authors include Franco Baldelli, Stefano Fiorucci, Sabrina Cipriani, Elisabetta Schiaroli, Anna Gidari, Adriana Carino, Andrea Mencarelli, Angela Zampella, Barbara Renga and Samuele Sabbatini and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and The Journal of Immunology.

In The Last Decade

Daniela Francisci

137 papers receiving 2.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniela Francisci Italy 27 1.0k 889 426 363 360 146 2.7k
Franco Baldelli Italy 31 778 0.7× 987 1.1× 735 1.7× 349 1.0× 491 1.4× 125 2.9k
June Myung Kim South Korea 32 876 0.8× 1.2k 1.4× 373 0.9× 261 0.7× 438 1.2× 202 3.6k
Miriam Lichtner Italy 31 1.5k 1.4× 1.1k 1.3× 224 0.5× 712 2.0× 400 1.1× 137 3.4k
Cristina Mussini Italy 29 1.4k 1.4× 900 1.0× 176 0.4× 388 1.1× 360 1.0× 159 3.1k
Alice K. Pau United States 20 1.5k 1.4× 1.4k 1.6× 232 0.5× 149 0.4× 138 0.4× 60 2.7k
Bruce Polsky United States 28 784 0.8× 1.4k 1.5× 197 0.5× 213 0.6× 269 0.7× 78 2.9k
Eugenia Quirós-Roldán Italy 32 2.0k 1.9× 1.1k 1.2× 484 1.1× 712 2.0× 520 1.4× 228 4.2k
P. Chavanet France 35 1.7k 1.6× 1.6k 1.8× 162 0.4× 141 0.4× 261 0.7× 186 3.5k
Giuliano Rizzardini Italy 34 2.5k 2.4× 1.2k 1.3× 478 1.1× 373 1.0× 613 1.7× 192 4.7k
Clara Lehmann Germany 25 1.4k 1.3× 611 0.7× 232 0.5× 789 2.2× 348 1.0× 122 3.2k

Countries citing papers authored by Daniela Francisci

Since Specialization
Citations

This map shows the geographic impact of Daniela Francisci's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniela Francisci with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniela Francisci more than expected).

Fields of papers citing papers by Daniela Francisci

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniela Francisci. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniela Francisci. The network helps show where Daniela Francisci may publish in the future.

Co-authorship network of co-authors of Daniela Francisci

This figure shows the co-authorship network connecting the top 25 collaborators of Daniela Francisci. A scholar is included among the top collaborators of Daniela Francisci based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniela Francisci. Daniela Francisci is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Pariano, Marilena, Anna Gidari, Claudia Stincardini, et al.. (2024). Protective Effect of Indole-3-Aldehyde in Murine COVID-19-Associated Pulmonary Aspergillosis. Journal of Fungi. 10(7). 510–510. 2 indexed citations
3.
Pallotto, Carlo, et al.. (2023). Adherence to 2015 ESC Guidelines for the Treatment of Infective Endocarditis: A Retrospective Multicentre Study (LEIOT Study). Antibiotics. 12(4). 705–705. 2 indexed citations
4.
Brescini, Lucia, et al.. (2023). Kaposi Sarcoma in people living with HIV: is it water under the bridge?. Mediterranean Journal of Hematology and Infectious Diseases. 15(1). e2023027–e2023027. 2 indexed citations
5.
Gidari, Anna, Samuele Sabbatini, Elisabetta Schiaroli, et al.. (2023). The hope and hype of ellagic acid and urolithins as ligands of SARS-CoV-2 Nsp5 and inhibitors of viral replication. Journal of Enzyme Inhibition and Medicinal Chemistry. 38(1). 2251721–2251721. 8 indexed citations
6.
Gidari, Anna, Samuele Sabbatini, Sabrina Bastianelli, et al.. (2021). SARS-CoV-2 Survival on Surfaces and the Effect of UV-C Light. Viruses. 13(3). 408–408. 86 indexed citations
7.
Bartolini, Desirée, Anna Maria Stabile, Sabrina Bastianelli, et al.. (2021). SARS-CoV2 infection impairs the metabolism and redox function of cellular glutathione. Redox Biology. 45. 102041–102041. 68 indexed citations
8.
Campogiani, Laura, Mirko Compagno, Luigi Coppola, et al.. (2019). Tuberculosis-Related Hospitalizations in a Low-Incidence Country: A Retrospective Analysis in Two Italian Infectious Diseases Wards. International Journal of Environmental Research and Public Health. 17(1). 124–124. 2 indexed citations
9.
Francisci, Daniela, Matteo Pirro, Elisabetta Schiaroli, et al.. (2019). Maraviroc Intensification Modulates Atherosclerotic Progression in HIV-Suppressed Patients at High Cardiovascular Risk. A Randomized, Crossover Pilot Study. Open Forum Infectious Diseases. 6(4). ofz112–ofz112. 42 indexed citations
10.
Socio, Giuseppe Vittorio De, Paolo Maggi, Elena Ricci, et al.. (2019). Smoking Habits in Human Immunodeficiency Virus-Infected People from Italy: A Cross-Sectional Analysis of the STOPSHIV Cohort. AIDS Research and Human Retroviruses. 36(1). 19–26. 8 indexed citations
11.
Tascini, Carlo, Vittorio Attanasio, Marco Ripa, et al.. (2019). Ceftobiprole for the treatment of infective endocarditis: A case series. Journal of Global Antimicrobial Resistance. 20. 56–59. 34 indexed citations
12.
Falcinelli, Emanuela, Daniela Francisci, Elisabetta Schiaroli, et al.. (2018). Effect of aspirin treatment on abacavir-associated platelet hyperreactivity in HIV-infected patients. International Journal of Cardiology. 263. 118–124. 12 indexed citations
14.
Bassetti, Matteo, Novella Carannante, Carlo Pallotto, et al.. (2018). KPC-producing Klebsiella pneumoniae gut decolonisation following ceftazidime/avibactam-based combination therapy: A retrospective observational study. Journal of Global Antimicrobial Resistance. 17. 109–111. 7 indexed citations
15.
Cappanera, Stefano, et al.. (2016). Non dimentichiamo la sindrome di Lemierre. Recenti Progressi in Medicina. 107(9). 487–491. 1 indexed citations
16.
Burkert, Francesco, et al.. (2016). Splenic tuberculosis in a patient with newly diagnosed advanced HIV infection. IDCases. 6. 20–22. 1 indexed citations
17.
Francisci, Daniela, Elisabetta Schiaroli, Monia Capponi, et al.. (2009). Management of Hepatitis B Virus Reactivation in Patients with Hematological Malignancies Treated with Chemotherapy. Infection. 38(1). 58–61. 47 indexed citations
18.
Belfiori, Barbara, et al.. (2008). Peginterferon plus Ribavirin for chronic hepatitis C in opiate addicts on methadone/buprenorphine maintenance therapy. Digestive and Liver Disease. 41(4). 303–307. 30 indexed citations
19.
Malincarne, Lisa, et al.. (2006). Penetration of moxifloxacin into bone in patients undergoing total knee arthroplasty. Journal of Antimicrobial Chemotherapy. 57(5). 950–954. 40 indexed citations
20.
Francisci, Daniela, et al.. (1995). Prevalence of HBV, HDV and HCV hepatitis markers in HIV-positive patients. European Journal of Epidemiology. 11(2). 123–126. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026